INTERIM FORMULARY UPDATE
|
|
- Lynette Rogers
- 5 years ago
- Views:
Transcription
1 INTERIM FORMULARY UPDATE The fllwing recmmendatins, made at the July 29, 2016 meeting f the Executive Frmulary Cmmittee, are apprved: Prduct(s) deleted frm the DADS/DSHS Drug Frmulary: Generic Name Brand Name Dsage frms t be deleted Dsage frms still available Aminphylline Injectin: 25 /ml Nne Suppsitry, rectal: 250 Tablet: 200 Salmeterl Serevent Aersl, inhalatin: 25 Pwder, inhalatin: 50 mcg mcg/dse Terbutaline Aersl, ral: 0.2 /actuatin Injectin: 1 /ml Tablet: 2.5, 5 Thephylline Capsule, timed release (12 Nne hur): 130, 260 Capsule, timed release (24 hur); 100, 200, Slutin, ral: 80 /15 ml, 150 /15 ml Tablet, immediate release (Sl-phyllin ): 100, 125, 200, 250, Tablet, timed release: Thelair SR (8-12 hur): 100, 200, 250,, 500 The-Dur (8-24 hur): 100, 200,, 450 Thephylline SR (12-24 hur): 100, 200, Uniphyl (24 hur): 400 Tablet, timed release (12 hur): 100, 200, Triamcinlne Aersl, ral, inhalatin: 100 mcg/metered spray Aersl, tpical: 0.2/2 secnd spray Cream, tpical: 0.025%, 0.1%, 0.5% Ltin, tpical: 0.25%, 0.1% Ointment, tpical: 0.25%, 0.1%, 0.5% Spray, intranasal: 55 mcg/actuatin [100 Brmpheniraminepseudephedrine Capsule: Brmpheniramine 12 pseudephedrine `20 Elixir: brmpheniramine 4 pseudephedrine 30 Liquid: brmpheniramine 12 pseudephedrine 1 per 5 ml Syrup: brmpheniramine 2 pseudephedrine 30 Tablet, sustained release: brmpheniramine 8 pseudephedrine 120 sprays/canister] Liquid: brmpheniramine 15 pseudephedrine 1 per 5 ml Tablet: brmpheniramine 4 pseudephedrine 60 Page 1
2 Generic Name Brand Name Dsage frms t be deleted Dsage frms still available Chlrpheniramine Capsule: 12 Tablet: 8, 12 Tablet, chewable: 2 Syrup: 2 /5 ml Tablet: 4 Tablet, timed release: 12 Tablet, timed release: 8 Diphenhydramine Tablet: 50 Capsule: 25, 50 Cream, tpical:2% Injectin: 50 /ml Liquid, ral: 12.5 /5 ml Phenylephrine Slutin, nasal, drps: 0.25%, 0.5% Pseudephedrine Tablet, timed release: 120 Tablet, extended release: 240 Triprlidinepseudephedrine Guaifenesin Capsule, extended release: Triprlidine 5 pseudephedrine 120 Syrup: Triprlidine 1.25 pseudephedrine 30 per 10 Caplet, sustained release: 600 Liquid, ral: 200 /5 ml Tablet: 100 Ltin: 1% Slutin, nasal, drps: 0.125% Slutin, nasal, spray: 0.25%,0.5%, 1% Slutin, phthalmic: 2.5%, 10% Liquid, ral: 15 /5 ml, 30 /5 ml Tablet, immediate release: 30, 60 Tablet, extended release: 120 Tablet: Triprlidine 2.5 pseudephedrine 60 Liquid, ral: 100 /5 ml Tablet: 200, 400 Tablet, sustained release: 600 Ptassium idide Slutin, ral: 100 /ml Slutin, ral: 1 g/ml Cetirizine Tablet, chew: 5, 10 Syrup: 1 /ml Tablet: 5, 10 Hydrxyzine Suspensin: 25 /5 ml Tablet: 100 Capsule: 25, 50, 100 Injectin, as hydrchlride: 25 /ml, 50 /ml Syrup, as hydrchlride: 10 /5 ml Tablet: 10, 25, 50 Other Recmmendatin(s)/additin(s)/revisins(s) t the tables listed in the DADS/DSHS Drug Frmulary Fr this Dermatlgical sectin the fllwing changes were recmmended: Acne Sectin Benzyl Perxide Delete: Bar: 5% Cream, tpical 10% Gel, tpical: 2.5% Ltin: 10% Pads: 9% Erythrmycin-Benzyl Perxide (Benzamycin ) Change listing t: Gel, tpical: Erythrmycin 3% - Benzyl Perxide 5% (with 20% alchl) Salicylic Acid Sulfur Delete: Bar Cream Gel Sulfacetamide Sdium Delete trade name Sebizn Delete Gel: 10% Tretinin Gel Page 2
3 Delete Gel frm the listing Delete: Gel, tpical: 0.01% Liquid, tpical: 0.05% Anesthetics, Lcal Benzcaine Delete Spray: 5% Ethyl Chlride Delete all sizes Lidcaine Delete: Gel, tpical: 2.5% Liquid, tpical: 2.5%, 4% Ointment, tpical: 2.5% Mve Liquid, viscus 2% t muth and thrat sectin Pramxine Delete trade name Trnthane Delete - Ointment, tpical: 1% Anti-Histamine Agents Delete bttle sizes frm the fllwing prducts: Calamine-Zinc Oxide-Glycerin Calamine-Pramxine Delete diphenhydramine ltin: 1% Anti-Infectives Antibitics Bacitracin-Plymyxin B Delete Pwder, tpical: Bacitracin 500 units Plymyxin B 10,000 units/g Plymyxin B-Nemycin Delete Cream: Plymyxin B 10,000 units Nemycin 3.5 Deletin remves Plymyxin B-Nemycin frm the frmulary as there are n prducts with this cmbinatin Anti-Infectives Antiviral Acyclvir Change cream listing frm 0.5% t 5% Ointment, tpical 5% [50 /g] delete all sizes Anti-Infectives Antifungals Delete all trade names listed in this sectin Cltrimazle Delete Ltin: 1% Micnazle Delete Ltin: 2% Anti-Infectives Antipsriatics Cal Tar Delete trade names Inil-T, Tegrin, Pentrax, Plytar Delete the fllwing prducts: Cream, tpical: 2% Liquid, tpical: 30% Shamp: 5% Slutin, tpical: 120 ml, 480 ml Add Shamp: 0.5% Selenium Sulfide Delete trade name Selsun Anti-Infectives Antisebrrheic Agents Cal Tar Delete trade names Inil-T, Tegrin, Pentrax, Plytar Delete the fllwing prducts: Cream, tpical: 2% Page 3
4 Liquid, tpical: 30% Shamp: 5% Slutin, tpical: 120 ml, 480 ml Add Shamp: 0.5% Salicylic Acid-Sulfur Delete the fllwing prducts: Bar Cream Gel Selenium Sulfide Delete trade name Selsun Sulfacetamide Sdium Delete trade name Sebizn Anti-Infectives Antiseptics & Germicides Chlrhexidine delete trade names Hibiclens, Bactshield Hexachlrphene delete trade name phishex Pvidne-Idine Delete all package sizes Delete Cleanser, tpical Change Slutin, prep t Surgical Scrub: 7.5% Burn Agents Bacitracin delete trade name Baciguent Crticsterids Betamethasne diprpinate Delete Gel: 0.05% Flucinnide Delete trade name Lidex Delete the fllwing prducts: Cream, tpical:1%, 2.5% Ltin, tpical: 1%, 2%, 2.5% Ointment, tpical: 1%, 2.5% Betamethasne valerate Delete Cream, tpical: 0.01% Triamcinlne Delete trade names Aristcrt, Kenacrt Desnide Delete trade name Lkara Hydrcrtisne Delete trade names Lanacrt, Crticaine Delete Ltin, tpical: 0.5% Diaper Rash Agents Fr the diaper rash sectin, n specific prducts will be listed. Any prduct used as a Diaper Rash prduct will be cnsidered Frmulary Emllients Emllient Gel delete trade name Clinac O.C. Emllient Ltin delete trade names Allercreme, Lac-Hydrin Keratlytics Salicylic Acid Delete individual listings f prducts Add statement: All available salicylic acid prducts as a single agent are cnsidered t be n frmulary. Urea Delete percentages ff the listing which makes all percentages n frmulary Delete Shamp Ointments & Ltin Bases Change sectin title t Ointments Page 4
5 Petrlatum, white Delete package size frm Ointment, tpical Rubs and Liniments Menthl Menthl is rarely fund as an single ingredient List menthl nly with n prducts listed Menthl-Methyl salicylate Delete the strength (30%) frm the Cream, tpical listing Add: Ointment, tpical Skin Cleansers Abrasive Cleanser Delete the Abrasive Cleanser sectin as many f these cntain salicylic acid which is listed separately Salicylic Acid-Sulfur Delete the prduct listings and add the fllwing statement: All cmmercially available frms are n frmulary. Scabicides & Pediculicides Permethrin Delete trade name Acticin Change Shamp t Cream Rinse Pyrethins 0.33%-Pipernyl Butxide 4% Delete Shamp: 0.3% Skin Prtectants Benzin, Cmpund Tincture Delete sizes frm the listing Change the als cntains t may als cntain Zinc Oxide Delete the percentages frm the intment and paste entries which makes all percentages n frmulary Tar-Cntaining Agents Cal tar Delete trade names Inil-T, Tegrin, Pentrax, Plytar Delete the fllwing prducts: Cream, tpical: 2% Liquid, tpical: 30% Shamp: 5% Slutin, tpical: 120 ml, 480 ml Add Shamp: 0.5% Wund Agents Cllagenase Delete the strengths frm the intment, tpical listing Trypsin-balsam Peru-Castr Oil Delete the fllwing trade names GranulDerm, Vaslex, Xenaderm Change listings t: Aersl Ointment Wund Cleanser Change trade name t Karringtn Clara-Klenz Miscellaneus Dermatlgicals Trypsin-balsam Peru-Castr Oil Delete the fllwing trade names GranulDerm, Vaslex, Xenaderm Change listings t: Aersl Ointment New Dsage Strengths t be added t the frmulary Page 5
6 Add 1% - hydrcrtisne, 1 % fam (Prctfam HC) Based n the Nvel Oral Anticagulant Review Add the fllwing Generic Name Brand Name Dsage Frm Classificatin Rivarxaban Xarelt Tablet: 10, 15, 20 Anticagulant Other recmmendatin: Mve terbutaline t the Geniturinary Sectin. Apprved: Ann Richrads, Pharm.D., BCPP Ann Richards, Pharm., D., BCPP Pharmacy Services Directr San Antni State Hspital Page 6
Dosage Administration
Pharmacy Technician Dsage Administratin Dsage Administratin Dsage Frms and Their Usages Medicatins ften cnsist f small quantities f active ingredients cmbined with inactive ingredients t create varius
More informationThis table cannot be relied upon in the absence of: PA Medical Directive #4 Otolaryngology
Title and Number f Directive: Order Table PA-4: Otlarynglgy This table cannt be relied upn in the absence f: PA Medical Directive #4 Otlarynglgy 1. OVERALL CONDITIONS - The PA may evaluate and prvide care
More informationSECTION O. MEDICATIONS
SECTION O. MEDICATIONS 1. NUMBER OF MEDICA TIONS (Recrd the number f different medicatins used in the last 7 days; enter "0" if nne used) O1. Number f Medicatins (7-day lk back) Intent: Prcess: Cding:
More informationThis table cannot be relied upon in the absence of: PA Medical Directive #16 Dermatology
Title and Number f Directive: Order Table PA-16: Dermatlgy This table cannt be relied upn in the absence f: PA Medical Directive #16 Dermatlgy 1. OVERALL CONDITIONS - The PA may evaluate and prvide care
More informationSummary of all approved changes are posted under Materials section at
Meeting called by: Pharmacy Services San Francisc Health Plan Pharmacy & Therapeutics Cmmittee Wednesday, Octber 18, 2018 7:30AM 9:30AM 50 Beale St., 13 th Flr, San Francisc, CA 94119 James Glauber, MD
More informationFamily Medicine Clinical Pharmacy Forum Vol. 3, Issue 5 (September/October 2007)
1 Family Medicine Clinical Pharmacy Frum Vl. 3, Issue 5 (September/Octber 2007) Family Medicine Clinical Pharmacy Frum is a brief bi-mnthly publicatin frm the Family Medicine clinical pharmacists distributed
More informationOriginal Policy Date 12:2013
MP 5.01.18 Xlair (Omalizumab) Medical Plicy Sectin Prescriptin Drugs Issu12:2013e 4:2006 Original Plicy Date 12:2013 Last Review Status/Date Lcal plicy/12:2013 Return t Medical Plicy Index Disclaimer Our
More informationColonoscopy Colyte Split-dose Prep Guide
Clnscpy Clyte Split-dse Prep Guide Yu have been scheduled fr a Clnscpy Clyte Split-dse Prep. Plan ahead t help reduce yur stress. Use these step-by-step instructins fr a successful prep s that yur dctr
More informationOffice of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS
Acetaminophen 80mg/0.8mL Suspension Drops Acetaminophen 120mg Suppository Acetaminophen 160mg/5mL Suspension Acetaminophen 325mg Suppository Acetaminophen 325mg Tablet, Caplet, or Capsule Acetaminophen
More informationDiphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Polio-Haemophilus Influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib-HB)
Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Pli-Haemphilus Influenzae type b Cnjugate Cmbined Vaccine Bilgical Page (DTaP-IPV-Hib-HB) Sectin 7: Bilgical Prduct Infrmatin Standard #: 07.214 Created
More informationPACKAGE LEAFLET INFORMATION FOR THE PATIENT
PACKAGE LEAFLET INFORMATION FOR THE PATIENT AMPICILLIN 125mg/5ml and 250mg/5ml ORAL SUSPENSION Please read all f this leaflet carefully befre yu start taking this medicine because it cntains imprtant infrmatin
More information-fl. Analysis of Oil-Based Pharmaceuticals 1. t---m
Analysis f Oil-Based Pharmaceuticals 1 EDWARD SMITH, Divisin f Drug Chemistry, Office f Pharmaceutical Research and Testing, Bureau f Drugs, Fd and Drug Administratin, Washingtn, D.C. 20204 ABSTRACT Oils
More informationPharmacy Program Updates: Quarterly Pharmacy Changes Effective January 1, 2017 and April 1, 2017
Pharmacy Prgram Updates: Quarterly Pharmacy Changes Effective January 1, 2017 and April 1, 2017 DRUG LIST (FORMULARY) CHANGES Based n the availability f new prescriptin medicatins and the Prime s Natinal
More informationDiphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Polio-Haemophilus Influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib-HB)
Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Pli-Haemphilus Influenzae type b Cnjugate Cmbined Vaccine Bilgical Page (DTaP-IPV-Hib-HB) Sectin 7: Bilgical Prduct Infrmatin Standard #: 07.214 Created
More informationTo remind workers that contact with poison oak can cause skin irritations. To educate workers about how to recognize poison oak.
Safety Training Tpic Purpse f Meeting T remind wrkers that cntact with pisn ak can cause skin irritatins. T educate wrkers abut hw t recgnize pisn ak. T cnsider ways t prtect yurself frm skin irritatins
More informationColonoscopy MoviPrep Split-dose Prep Guide
Yu have been scheduled fr a Clnscpy MviPrep Split-dse Prep. Plan ahead t help reduce yur stress. Use these step-by-step instructins fr a successful prep s that yur dctr can clearly view yur cln. If yu
More information2018 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST
2018 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST Note: Prescriptions for OTCs must be written by a Denver Health provider and filled at a Denver Health Pharmacy Drug Name Strength Dosage Form 80mg-160mg,
More informationWellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/03/2015.
More informationSTATE OF TENNESSEE DEPARTMENT OF FINANCE AND ADMINISTRATION DIVISION OF HEALTH CARE FINANCE AND ADMINISTRATION BUREAU OF TENNCARE
STATE OF TENNESSEE DEPARTMENT OF FINANCE AND ADMINISTRATION DIVISION OF HEALTH CARE FINANCE AND ADMINISTRATION BUREAU OF TENNCARE 310 Great Circle Rad NASHVILLE, TENNESSEE 37243 This ntice is t advise
More informationOphthalmology Field Advisory Committee September 20, 2018: Pharmacy Report : Linda Margulies M.D. and Mary Lynch M.D.
Ophthalmlgy Field Advisry Cmmittee September 20, 2018: Pharmacy Reprt : Linda Margulies M.D. and Mary Lynch M.D. Guests: Kelly Echevaria, PharmD, via cnference call Debbie Khachikian PharmD via written
More informationOpioid Analgesics PA Request Provider Checklist
WVP Health Authrity Updated 05-12-2015 Opiid Analgesics PA Request Prvider Checklist *** If pssible, please include the fllwing infrmatin with PA requests fr piid analgesics. Including the requested infrmatin
More information2019 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST
2019 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST Note: Prescriptions for OTCs must be written by a Denver Health provider and filled at a Denver Health Pharmacy ACETAMINOPHEN ALCOHOL ANTISEPTIC PADS
More informationDermatological preparations for the tropics
> * "» ' ' * ' * * '? *! =. *. * * -!! * * " * ' Dermatological preparations for the tropics J!»' % *; I,/,- * ""*'' ""'"" *'' ' : * - * ' * * f V * *? ' * S 3. '. s,,*,., «., - ; * (- J ; *;;; I r "*»
More informationCONSUMER MEDICINE INFORMATION
CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers sme cmmn questins abut CEFTRIAXONE lcp. It des nt cntain all the available infrmatin. It des nt take the place f talking t yur
More informationUPDATE WellCare s South Carolina
September 3, 2015 UPDATE WellCare s South Carolina Preferred Drug List Dear Provider: At the September 3, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More informationFamily Self-Care and Over the Counter Medications Program. Sponsored by: FAHC Department of Pharmacy
Family Self-Care and Over the Counter Medications Program Sponsored by: FAHC Department of Pharmacy What are Over the Counter Medications? Nonprescription medications and products Often referred to as
More informationAQUEOUS CREAM (450G) SDG$
AQUEOUS CREAM (450G) Soothes, softens and moisturizes your skin Emulsifying Wax, White Soft Paraffin, Liquid Paraffin. Moisturises dry skin. How Should I Use This Apply liberally to dry skin. What Should
More informationALLERGIC RHINITIS: ATTESTATION
Allergic Rhinitis Treatment Guidelines ALLERGIC RHINITIS: ATTESTATION. Effective Date: December 28, 2009 Reasn fr Attestatin: Annual review and update f existing guideline Key Guideline Updates/Revisins:
More informationMETHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY
METHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY 1.0 SCOPE AND APPLICATION 1.1 Methd 8032 is used t determine trace amunts f acrylamide mnmer in aqueus matrices. This methd may be applicable t ther matrices.
More informationOTC PRODUCTS. 4 Gama Benzene HCL 0.1% + Proflavine Hermisulphate 0.1% + Cetrimide 0.45% Cream
OTC PRODUCTS SR. No. COMPOSITION Allantoin 0.2% + Dimethicone 1% + Urea 10% + Propylene Glycol 5% + Glyserine 5% + 1 Light Liquid Paraffin 8% Cream (FOOT CREAM) 2 Aquous Cream 3 Cetrimide 0.5% + Chlorhexidine
More informationHead and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.
DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that
More informationWound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018
Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered
More informationPATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.
PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr
More informationOver The Counter (OTC) Self-Care Class. Dwight David Eisenhower Army Medical Center
Over The Counter (OTC) Self-Care Class Dwight David Eisenhower Army Medical Center Introduction to Health and Self-Care Over 70% of all medical appointments and Emergency Room visits for new problems may
More informationADDITIONAL DRUG LISTING FOR MEDICARE & MEDI-CAL MEMBERS
MEDICARE & MEDICAL MEMBERS! Please read carefully! The following pages include additional drugs which may be covered for you with your doctor s prescription by MediCal (Medicaid). These drugs CANNOT be
More information2015 Product Catalog. Phone: Fax: McCullough Drive, New Castle, DE
2015 Product Catalog Phone: 302-328-3355 Fax: 302-328-6968 50 McCullough Drive, New Castle, DE 19720 www.marlexpharm.com Phone: 302-328-3355 Fax: 302-328-6968 At Marlex Pharmaceuticals we are dedicated
More informationWellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/21/2017.
More informationThis table cannot be relied upon in the absence of: PA Medical Directive #3 - Ophthalmology
Title and Number f Directive: Order Table PA-3: Ophthalmlgy This table cannt be relied upn in the absence f: PA Medical Directive #3 - Ophthalmlgy 1. OVERALL CONDITIONS - The PA may evaluate and prvide
More informationTendon problems can happen in people of all ages who take levofloxacin. Tendons are tough cords of tissue that connect muscles to bones.
Medicatin Guide LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION, 25 mg/ml and LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION in 5% Dextrse fr Intravenus Use Read this Medicatin Guide befre yu start taking levflxacin
More informationProposed Preferred Drug List. Clinical Criteria
Prpsed Preferred Drug List with Clinical Criteria Prpsal fr TennCare August 26, 2008 Page 1 f 37 Respnsibilities f the TennCare Pharmacy Advisry Cmmittee Surce: Tennessee Cde/Title 71 Welfare/Chapter 5
More informationPERCENTAGE and RATIO STRENGTH
University of Kerbala College of Pharmacy Department of Pharmaceutics Principles of Pharmacy Practice Lecture 3 PERCENTAGE and RATIO STRENGTH Assistant lecturer Zahraa Alaa Hasan MSc. Drug Delivery 2018-2019
More informationImportant Pharmacy Information
Important Pharmacy Information There is no copay when your Primary Care Provider (PCP) or UnitedHealthcare Community Plan Specialist writes you a covered prescription. But you can get many over-the-counter
More informationCIPRODEX (ciprofloxacin and dexamethasone), otic suspension Initial U.S. Approval: 2003
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights d nt include all the infrmatin needed t use CIPRODEX safely and effectively. See full prescribing infrmatin fr CIPRODEX CIPRODEX (ciprflxacin and
More informationAcne. Findings: Open and/or closed comedones and inflammatory lesions, such as papules, pustules, and nodules
Applying Evidence-ased Guidelines t Primary Care Dermatlgy Friday 2:00 PM, Cncurrent Sessin E, Wrkshp WE04 Presenters: Jessica Zmlik, MD; Laura Zakwski, MD; Shbhina Chheda, MD, MPH, FACP University f Wiscnsin
More informationCancer Association of South Africa (CANSA)
Cancer Assciatin f Suth Africa (CANSA) Fact Sheet n Lichen Planus Intrductin Lichen planus (LP) is a disease f the skin and/r mucus membranes that resembles lichen. A lichen is a cmpsite rganism that emerges
More informationDrug Therapy Guidelines
Applicable Medical Benefit x Effective: 5/1/18 Pharmacy- Frmulary 1 x Next Review: 3/18 Pharmacy- Frmulary 2 x Date f Origin: 4/99 Gnadtrpin-Releasing Hrmne Agnists- Eligard, Luprn, Luprn-Dept, Luprn Dept-Ped,
More informationInfection Control Manual
This plicy has been adpted by UNC Health Care fr its use in infectin cntrl. It is prvided t yu as infrmatin nly. Infectin Cntrl Manual Plicy Name The Preventin f Intravascular Catheter- Related Infectins
More informationProvider Information: Influenza VISs
Prvider Infrmatin: Influenza VISs Thirteen influenza vaccine prducts are apprved fr use in the United States fr the 2014-15 influenza seasn: Name Manufacturer Age Range # f Strains Afluria bicsl 9 years
More informationPain relief after surgery
Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read
More informationFor External Use Only. Should neither be swallowed. Nor injected
For External Use Only Should neither be swallowed Nor injected Preparations which are applied to the skin. (Topical preparations) Preparations which are applied to the mucus membranes. Local effect Systemic
More informationAll Pharmacy Providers and Prescribing Practitioners. Subject: Updated and Revised Over-the-Counter Drug Formulary
Indiana Health Coverage Pros P R O V I D E R B U L L E T I N B T 2 0 0 3 5 8 A U G U S T 2 8, 2 0 0 3 To: All Pharmacy Providers and Prescribing Practitioners Subject: Overview Note: The information referenced
More informationGROUP 15 TOPICAL PREPARATIONS
- 105 - GROUP 15 15.1 DERMATOLOGICAL PREPARATIONS 15.1.1 TOPICAL ANTIFUNGALS CLOTRIMAZOLE Indication: Treatment of susceptible fungal infections, dermatophytoses, superficial mycoses, and cutaneous candidiasis
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Moapar mg powder and solvent for prolonged-release suspension for injection triptorelin
PACKAGE LEAFLET: INFORMATION FOR THE USER Mapar 11.25 mg pwder and slvent fr prlnged-release suspensin fr injectin triptrelin Read all f this leaflet carefully befre yu start using this medicine because
More informationPackage leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate
Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant
More informationPharmacy Providers and Prescribing Physicians. Updated Over-the-Counter Drug Formulary
P R O V I D E R B U L L E T I N BT200150 DECEMBER 12, 2001 To: Subject: Pharmacy Providers and Prescribing Physicians Note: The information in this bulletin is not directed to those providers rendering
More informationSAN LUIS OBISPO COUNTY HEALTH AGENCY
SAN LUIS OBISPO COUNTY HEALTH AGENCY Prtcl & Drug Frmulary Revisins / Additins Nvember 15, 2013 Public Health Department Emergency Medical Services Agency 2156 Sierra Way, San Luis Obisp, CA 93401 805-788-2511
More informationCalgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015
Calgary Long Term Care Formulary Pharmacy & Therapeutics February 2015 Highlights http://www.albertahealthservices.ca/4070.aspx 1 Contents February 2016... 3 Added Product(s)... 3 Not Listed, Delisted
More informationAsthma inhalers, medicines and treatments
Asthma inhalers, medicines and treatments Reliever inhalers Yur Emergency Rescue Reliever Everyne with asthma shuld ALWAYS carry a reliever (blue inhaler) inhaler at all the time s it s n hand in an emergency
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10
More informationXX Abraxane 100 MG SUSR (CELGENE CORP)
Plicy Medical Plicy Manual Apprved: D Nt Implement Until 1/31/19 Paclitaxel (Prtein-Bund) NDC CODE(S) 68817-0134-XX Abraxane 100 MG SUSR (CELGENE CORP) DESCRIPTION Paclitaxel is a natural prduct with antitumr
More informationAnnex E Terms of Reference: Therapeutic use
Annex E Terms f Reference: Therapeutic use The purpse f the pre-review reprt is t synthesize existing scientific evidence abut the therapeutic use and ptential fr dependence and abuse f cannabisrelated
More informationMedibios Laboratories Private Limited, India Nutraceutical / OTC & Cosmetics product List Product Description
Sr. No. Medibios Laboratories Private Limited, India Product Description 1 Calcium with Vitamin D3 and Mineral Tablets Each film-coated tablet contains: Calcium Carbonate BP equivalent to Elemental Calcium
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationo Prostanoids/prostacyclin therapies (oral and inhaled) o Inhaled agents: Ventavis, Tyvaso Page 1 of 5 Revised 02/17/17
Request fr Prir Authrizatin Pulmnary Arterial Hypertensin (PAH) Agents (Oral and Inhaled) Website Frm www.highmarkhealthptins.cm Submit request via: Fax - 1-855-476-4158 All requests fr Pulmnary Arterial
More informationPRODUCT LIST GENERAL - TABLETS
SR. NO. PRODUCT LIST GENERAL - TABLETS 1 Ciprofloxacin Tablets IP 500 mg 2 Ciprofloxacin And Tinidazole Tablets 3 Cefpodoxime Proxetil Tablets IP 4 Cefixime Dispersible Tablets 200 mg 5 Cefixime Dispersible
More informationSt. Louis Public School District PARENT PERMISSION FOR THE ADMINISTRATION OF OVER-THE- COUNTER MEDICATION
St. Louis Public School District PARENT PERMISSION FOR THE ADMINISTRATION OF OVER-THE- COUNTER MEDICATION Listed below are nonprescription medications that the nurses can give to students only with parent
More informationProcedure Information
Prcedure Infrmatin Yu are scheduled fr a Clnscpy. Please read all f the attached infrmatin as sn as pssible s yu are prepared fr yur upcming prcedure. PHYSICIAN PERFORMING PROCEDURE: DATE: PROCEDURE TIME:
More informationPackage leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Slutin fr injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationMEDICATION GUIDE. (Interferon alfa-2b)
MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationName of procedure: Removal of submandibular salivary gland
Oral facial surgery Surgical prcedure infrmatin leaflet Name f prcedure: Remval f submandibular salivary gland This leaflet explains sme f the benefits, risks and alternatives t the peratin. We want yu
More informationOVER-THE-COUNTER BENEFITS. Get Over-the-Counter Products Every Quarter
2019 Get Over-the-Counter Products Every Quarter OVER-THE-COUNTER BENEFITS As a member of Brand New Day, you have an Over-the-Counter (OTC) benefit every quarter This benefit allows you to get OTC products
More informationINTRAVENOUS FLUID THERAPY CLINICAL CARE RECOMMENDATIONS
INTRAVENOUS FLUID THERAPY CLINICAL CARE RECOMMENDATIONS Clinical Assessment Vital signs n admissin Evaluate hydratin status clinically Mnitring Vital signs per nursing prtcl Dcument intake and utput Onging
More informationEUROPEAN MEDICINES AGENCY DECISION. of 14 October 2008
Eurpean Medicines Agency Dc. Ref. EMEA/522876/2008 P/84/2008 EUROPEAN MEDICINES AGENCY DECISION f 14 Octber 2008 n the applicatin fr agreement f a Paediatric Investigatin Plan fr valsartan (Divan) (EMEA-000005-PIP01-07)
More informationHuman amniotic membrane grafts, for the treatment of all other ophthalmic conditions/diseases is considered investigational,
Medical Manual Human Amnitic Membrane Grafts and Amnitic Fluid Injectins DESCRIPTION Several cmmercially available frms f human amnitic membrane (HAM) and amnitic fluid can be administered by grafts, tpical
More informationPackage leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin Graduated Syringe 10,000 IU/ml Slutin fr Injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationQuick Reference ONS Supplement Guidance for Dietitian Reference
Quick Reference ONS Supplement Guidance fr Dietitian Reference This guideline shuld be fllwed t ensure apprpriate prescribing practices acrss the primary and secndary care interface in line with Suth West
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is
More informationOTC DRUGS' LIST. No Drug Name Dosage Form Route of Admin ATC Code Description Date
فهرست داروهاي OTC OTC DRUGS' LIST تاريخ توضيحات دسته دارو راه مصرف شكل دارويي نام دارو رديف No Drug Name Dosage Form Route of Admin ATC Code Description Date ١ ٢ ٣ ۴ ۵ ۶ ٧ ٨ ٩ ١٠ ١١ ١٢ ١٣ ١۴ A.C.A* TABLET
More informationTwo Day Colonoscopy Preparation PEG (GoLYTELY) & Dulcolax Prep
Tw Day Clnscpy Preparatin PEG (GLYTELY) & Dulclax Prep Thank yu fr chsing t have yur clnscpy with NSPG Gastrenterlgy. We are delighted t be able t participate in yur healthcare and we will make every attempt
More informationWVCH Formulary Additions Effective 01/01/2016 Name Strength Dosage Form Route Formulary Restrictions
WVCH Formulary Additions Effective 01/01/2016 Name Strength Dosage Form Route Formulary Restrictions ANORO ELLIPTA 62.5-25MCG BLST W/DEV INHALATION ARCAPTA NEOHALER 75 MCG CAP W/DEV INHALATION CALCIPOTRIENE
More informationCORTIZONE-10 Hydrocortisone Anti-Itch Cream Assorted Varieties 1 oz. Assortment varies by location $ Assortment varies by location.
June SALE! Start of Summer Sale ALEVE Naproxen Sodium 220 mg Tablets, 50 Count BAYER Aspirin 325 mg 5 99 PRILOSEC OTC Omeprazole 20.6 mg Tablets, 14 Count Additional select Aleve & Bayer items GOLD BOND
More informationXX Abraxane 100 MG SUSR (CELGENE CORP
Medical Manual Apprved Revised: D Nt Implement until 6/30/2019 Paclitaxel (Prtein-Bund) NDC CODE(S) 68817-0134-XX Abraxane 100 MG SUSR (CELGENE CORP DESCRIPTION Paclitaxel is a natural prduct with antitumr
More informationDRAFT Policy for the Management of Ear Wax
Clinical Cmmissining Grup (CCG) Treatment Plicy NHS Birmingham and Slihull Clinical Cmmissining Grup NHS Sandwell and West Birmingham Clinical Cmmissining Grup DRAFT Plicy fr the Management f Ear Wax 1
More informationInfection Control. Three Ways Germs Are Spread Germs are spread in the environment three ways: direct contact, indirect contact, and droplet spread.
Infectin Cntrl Infectin cntrl is preventing the spread f germs that cause illness and infectin. Infectin cntrl starts with understanding germs and hw they are spread. Abut Germs Everyne cmes in cntact
More informationDiphtheria-Tetanus-Acellular Pertussis Combined Vaccine Biological Page (dtap)
Diphtheria-Tetanus-Acellular Pertussis Cmbined Vaccine Bilgical Page (dtap) Sectin 7: Bilgical Prduct Infrmatin Standard #: 07.210 Created by: Apprved by: Prvince-wide Immunizatin Prgram Standards and
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) June 2017 Review: June 2020 Bulletin 251: The Management f Hyperhidrsis Bedfrdshire and Hertfrdshire INTERIM Pririties Frum Guidance JPC Recmmendatins:
More informationREVISION: PHOTOSYNTHESIS & CELLULAR RESPIRATION 18 JUNE 2014
REVISION: PHOTOSYNTHESIS & CELLULAR RESPIRATION 18 JUNE 2014 Lessn Descriptin In this lessn, we revise: the prcess f phtsynthesis the prcesses invlved in cellular respiratin Summary Phtsynthesis (Slutins
More informationExamples of prices, license restrictions and availability of common over the counter medications.
Examples of s, license restrictions and availability of common over the counter medications. GSL items can be purchased from any er. Supermarkets and discount stores may be more cost effective than pharmacies.
More informationSummary of Changes to the Alberta Human Services Drug Benefit Supplement
Summary of Changes to the Alberta Human Services Drug Benefit Supplement Effective April 1, 2012 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J
More informationLABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION
LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION Added Prior Authorization 7/1/17 CORLANOR 5 MG TABLET Added Prior Authorization 7/1/17 CORLANOR 7.5 MG TABLET Added Prior Authorization 7/1/17
More informationUse of sacubitril valsartan for the treatment of symptomatic chronic heart failure with reduced ejection fraction. Shared Care Protocol
Oxfrdshire Clinical Cmmissining Grup Use f sacubitril valsartan fr the treatment f symptmatic chrnic heart failure with reduced ejectin fractin. Shared Care Prtcl This prtcl prvides prescribing and mnitring
More informationFinding the right 90 people in 90 days and what to do with them:
Finding the right 90 peple in 90 days and what t d with them: Wh can yu give the 3 packets (with instructins) t? Current Preferred Custmers nt currently n the Daily Essentials Packets. Friends and Family
More informationProcedure Information
Prcedure Infrmatin Yu are scheduled fr a Clnscpy. Please read all f the attached infrmatin as sn as pssible s yu are prepared fr yur upcming prcedure. PHYSICIAN PERFORMING PROCEDURE: DATE: PROCEDURE TIME:
More informationNew Zealand Consumer Medicine Information. Tramadol hydrochloride immediate release capsules (50 mg) and solution for injection (50 mg/ml, 100 mg/2ml)
New Zealand Cnsumer Medicine Infrmatin TRAMAL Tramadl hydrchlride immediate release capsules (50 mg) and slutin fr injectin (50 mg/ml, 100 mg/2ml) What is in this leaflet Please read this leaflet carefully
More informationPREPHERALLY INSERTED VENOUS CATHETERS (MIDLINE CATHETERS)
CVC MID REV12/2016 PREPHERALLY INSERTED VENOUS CATHETERS (MIDLINE CATHETERS) Instructins fr use Intended use: Sterile single use device indicated t be placed peripherally in the upper arm veins fr use
More informationConcentrations and Dilutions INTRODUCTION. L earning Objectives CHAPTER
CHAPTER 6 Concentrations and Dilutions L earning Objectives After completing this chapter, you should be able to: INTRODUCTION Concentrations of many pharmaceutical preparations are expressed as a percent
More informationHealthStuff TM More of the stuff you want
2010 HealthStuff TM More of the stuff you want 31296 M0012_NA010065_WCM_OTC_ENG WellCare 2010 HI_12_09 HI_OTC_ENG_10065_1209 Getting your HealthStuff is EASY Welcome to HealthStuff! With HealthStuff, you
More information